Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 918,499 | 790,471 | 718,175 | 648,726 | 581,939 |
| Cost of Goods | 159,682 | 140,794 | 127,435 | 115,804 | 101,692 |
| Gross Profit | 758,817 | 649,677 | 590,740 | 532,922 | 480,247 |
| Operating Expenses | 617,837 | 534,369 | 474,463 | 435,547 | 403,683 |
| Operating Income | 141,662 | 116,102 | 116,712 | 98,179 | 77,256 |
| Interest Expense | 15 | 129 | 1 | 20 | 9 |
| Other Income | 942 | -320 | -130 | 267 | 231 |
| Pre-tax Income | 142,589 | 115,653 | 116,581 | 98,426 | 77,478 |
| Income Tax | 47,917 | 39,017 | 37,557 | 31,993 | 26,726 |
| Net Income Continuous | 94,672 | 76,636 | 79,024 | 66,433 | 50,752 |
| Net Income | $94,672 | $76,636 | $79,024 | $66,433 | $50,752 |
| EPS Basic Total Ops | 3.72 | 2.90 | 2.89 | 2.29 | 1.65 |
| EPS Basic Continuous Ops | 3.72 | 2.90 | 2.89 | 2.28 | 1.65 |
| EPS Diluted Total Ops | 3.59 | 2.80 | 2.78 | 2.23 | 1.63 |
| EPS Diluted Continuous Ops | 3.59 | 2.80 | 2.78 | 2.23 | 1.63 |
| EBITDA(a) | $151,640 | $124,912 | $125,756 | $107,005 | $85,730 |